• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善心律失常治疗的遗传框架。

A genetic framework for improving arrhythmia therapy.

作者信息

Knollmann Björn C, Roden Dan M

机构信息

Vanderbilt University School of Medicine, 1285 Medical Research Building IV, Nashville, Tennessee 37232, USA.

出版信息

Nature. 2008 Feb 21;451(7181):929-36. doi: 10.1038/nature06799.

DOI:10.1038/nature06799
PMID:18288182
Abstract

Abnormalities in heart rhythm continue to cause high rates of illness and death. Better treatment could be provided by solving two main challenges: the early identification of patients who are at risk, and the characterization of molecular pathways that culminate in arrhythmias. By analysing mechanisms that increase susceptibility to arrhythmia in individuals with genetic syndromes, it might be possible to improve current therapies and to develop new ways to treat and prevent common arrhythmias.

摘要

心律失常异常持续导致高发病率和高死亡率。通过解决两个主要挑战可以提供更好的治疗方法:早期识别有风险的患者,以及确定导致心律失常的分子途径特征。通过分析增加患有遗传综合征个体心律失常易感性的机制,有可能改进当前疗法并开发治疗和预防常见心律失常的新方法。

相似文献

1
A genetic framework for improving arrhythmia therapy.改善心律失常治疗的遗传框架。
Nature. 2008 Feb 21;451(7181):929-36. doi: 10.1038/nature06799.
2
Susceptibility genes and modifiers for cardiac arrhythmias.心律失常的易感基因和修饰基因
Cardiovasc Res. 2005 Aug 15;67(3):397-413. doi: 10.1016/j.cardiores.2005.04.005.
3
The year in electrophysiology.
J Am Coll Cardiol. 2004 Apr 7;43(7):1306-14. doi: 10.1016/j.jacc.2004.01.027.
4
Sudden cardiac death: mechanisms, therapies and challenges.心脏性猝死:机制、治疗与挑战
Nat Clin Pract Cardiovasc Med. 2005 Jul;2(7):352-60. doi: 10.1038/ncpcardio0241.
5
Genetic arrhythmias.遗传性心律失常
Ital Heart J. 2005 Mar;6(3):241-8.
6
Model systems for the discovery and development of antiarrhythmic drugs.用于抗心律失常药物发现与开发的模型系统。
Prog Biophys Mol Biol. 2008 Oct-Nov;98(2-3):328-39. doi: 10.1016/j.pbiomolbio.2008.10.009. Epub 2008 Nov 11.
7
[Brugada syndrome, newcomer among inherited cardiac arrhythmias].
Duodecim. 2005;121(12):1301-8.
8
The primary arrhythmia syndromes: same mutation, different manifestations. Are we starting to understand why?原发性心律失常综合征:相同的突变,不同的表现。我们是否开始明白原因了呢?
J Cardiovasc Electrophysiol. 2008 Apr;19(4):445-52. doi: 10.1111/j.1540-8167.2007.01073.x. Epub 2008 Feb 12.
9
German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management.德国心脏病学会细胞电生理学工作组最新论文:分子机制对临床心律失常管理的影响。
Clin Res Cardiol. 2019 Jun;108(6):577-599. doi: 10.1007/s00392-018-1377-1. Epub 2018 Oct 10.
10
Genetic mutations and arrhythmia: simulation from DNA to electrocardiogram.基因突变与心律失常:从DNA到心电图的模拟
J Electrocardiol. 2007 Nov-Dec;40(6 Suppl):S47-50. doi: 10.1016/j.jelectrocard.2007.05.033.

引用本文的文献

1
-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in Mice.-Verticilide B1 抑制型 2 兰尼碱受体通道,并在小鼠中具有抗心律失常作用。
Mol Pharmacol. 2024 Feb 15;105(3):194-201. doi: 10.1124/molpharm.123.000752.
2
Towards Improved Human Models for Cardiac Arrhythmia: Disease Mechanisms, Treatment, and Models of Atrial Fibrillation.迈向改进的心律失常人体模型:疾病机制、治疗及心房颤动模型
Biomedicines. 2023 Aug 23;11(9):2355. doi: 10.3390/biomedicines11092355.
3
Timing mechanisms to control heart rhythm and initiate arrhythmias: roles for intracellular organelles, signalling pathways and subsarcolemmal Ca.
控制心律和引发心律失常的时间机制:细胞内细胞器、信号通路和肌小节下 Ca 的作用。
Philos Trans R Soc Lond B Biol Sci. 2023 Jun 19;378(1879):20220170. doi: 10.1098/rstb.2022.0170. Epub 2023 May 1.
4
In Vivo Pharmacokinetic and Pharmacodynamic Properties of the Antiarrhythmic Molecule -Verticilide.抗心律失常分子——Verticilide 的体内药代动力学和药效学特性。
J Pharmacol Exp Ther. 2023 Jun;385(3):205-213. doi: 10.1124/jpet.122.001455. Epub 2023 Mar 9.
5
Effect of high-throughput screening of circRNA01724 on a rat model of myocardial ischemia ventricular arrhythmia.环状RNA01724高通量筛选对大鼠心肌缺血性室性心律失常模型的影响
J Thorac Dis. 2022 Apr;14(4):1172-1182. doi: 10.21037/jtd-22-194.
6
Microengineered platforms for characterizing the contractile function of in vitro cardiac models.用于表征体外心脏模型收缩功能的微工程平台。
Microsyst Nanoeng. 2022 Feb 28;8:26. doi: 10.1038/s41378-021-00344-0. eCollection 2022.
7
The Purkinje-myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT.浦肯野-心肌连接处是 CPVT 中室性心律失常的解剖起源。
JCI Insight. 2022 Feb 8;7(3):e151893. doi: 10.1172/jci.insight.151893.
8
RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT.RYR2 通道抑制是氟卡尼在 CPVT 中作用的主要机制。
Circ Res. 2021 Feb 5;128(3):321-331. doi: 10.1161/CIRCRESAHA.120.316819. Epub 2020 Dec 10.
9
R-From-T as a Common Mechanism of Arrhythmia Initiation in Long QT Syndromes.R 从 T 作为长 QT 综合征中心律失常起始的共同机制。
Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e007571. doi: 10.1161/CIRCEP.119.007571. Epub 2019 Dec 16.
10
Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.患者独立的人类诱导多能干细胞模型:快速确定长 QT 综合征中遗传变异致病性的新工具。
Heart Rhythm. 2019 Nov;16(11):1686-1695. doi: 10.1016/j.hrthm.2019.04.031. Epub 2019 Apr 18.